Doç. Dr. LÜTFİYE DEMİR

Makaleler 50

1. Significance of High-Mobility Group A Protein 2 Expression in Pancreatic Ductal Adenocarcinoma and Ampullary Adenocarcinoma

Oflas D., Canaz F., Özer İ., Demir L., Çolak E.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , cilt.34, sa.10, ss.1014-1024, 2023 (SCI-Expanded, Scopus, TRDizin)

2. A Real-World Comparison of Pazopanib Versus Sunitinibin Metastatic Renal Cell Carcinoma:Focus on Poor-Risk patients, A Single-Center Study

Demir L., Bayır D., Ozdogan R., Yıldız B., Dincer M.

Journal of oncological sciences , cilt.6, sa.3, ss.153-163, 2020 (Scopus, TRDizin)

3. BRAF Mutant Metastatik Melanomda Dabrafenib-trametinib Kombinasyon Tedavisi Sonrası Gelişen Yan Etki Yönetimi: İki Olgu Sunumuyla Birlikte Literatür Derlemesi

Karateke Y., Demir L.

Osmangazi Tıp Dergisi , cilt.42, sa.5, ss.588-595, 2020 (TRDizin)

4. Factors affecting the disease free and overall survival following neoadjuvant chemotherapy in patients with local advanced breast cancer

Acar T., Kamer K. E., Demir L., Tarcan E., Gür E. Ö., Atahan M. K., et al.

Journal of Surgical Arts , cilt.13, sa.1, ss.1-10, 2020 (Hakemli Dergi)

5. Fragmented QRS formation and its predictors in patients with breast cancer receiving anthracycline-based chemotherapy

Dural M., Demir L., Babayigit E., Junushova B., Mert K. U., Ulus T., et al.

JOURNAL OF ELECTROCARDIOLOGY , cilt.54, ss.5-9, 2019 (SCI-Expanded, Scopus)

6. A rare case of primary extra-osseous Ewing’s sarcoma presenting in the posterior neck

Emekli E., Toprak U., Şaylısoy S., Demir L.

ORTADOĞU TIP DERGİSİ , cilt.11, sa.4, ss.626-630, 2019 (TRDizin)

7. The prognostic role of thyroid transcription factor-1 in lung adenocarcinoma

Oktay E., Oflazoglu U., Varol Y., Tanriverdi O., Mermur N., Arda H. U., et al.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , cilt.14, 2018 (SCI-Expanded, Scopus)

8. The maximum standardized uptake value of metastatic site in 18 F-FDG PET/CT predicts molecular subtypes and survival in metastatic breast cancer: An Izmir Oncology Group study

Cokmert S., Tanriverdi O., Karapolat I., Demir L., Bayoglu V., Can A., et al.

JOURNAL OF BUON , cilt.21, ss.1410-1418, 2016 (SCI-Expanded, Scopus)

9. Quality of life in colorectal cancer patients: an Izmir Oncology Group (IZOG) study

Akyol M., Ulger E., Alacacioglu A., Kucukzeybek Y., Bayoglu V., Yildiz Y., et al.

JOURNAL OF BUON , cilt.20, ss.1015-1022, 2015 (SCI-Expanded, Scopus)

10. Prognostic value of mesothelin expression in patients with triple negative and HER2-positive breast cancers

Bayoglu I. V., Kucukzeybek B. B., Kucukzeybek Y., Varol U., Yildiz I., Alacacioglu A., et al.

BIOMEDICINE & PHARMACOTHERAPY , cilt.70, ss.190-195, 2015 (SCI-Expanded, Scopus)

11. Comparison of first-line bevacizumab in combination with mFOLFOX6 or XELOX in metastatic colorectal cancer

Bayoglu I. V., Yildiz I., Varol U., Cokmert S., Kucukzeybek Y., Alacacioglu A., et al.

JOURNAL OF BUON , cilt.20, ss.460-467, 2015 (SCI-Expanded, Scopus)

12. Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?

Dirican A., Kucukzeybek B. B., Alacacioglu A., Kucukzeybek Y., Erten C., Varol U., et al.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , cilt.20, ss.70-81, 2015 (SCI-Expanded, Scopus)

13. The Effects of Adjuvant Endocrine Treatment on Serum Leptin, Serum Adiponectin and Body Composition in Patients with Breast Cancer: The Izmir Oncology Group (IZOG) Study

Akyol M., Demir L., Alacacioglu A., Ellidokuz H., Kucukzeybek Y., Yildiz Y., et al.

CHEMOTHERAPY , cilt.61, ss.57-64, 2015 (SCI-Expanded, Scopus)

14. Uracil/tegafur as a possible salvage therapy in chemo-refractory colorectal cancer patients: a single institutional retrospective study

Bayoglu I. V., Yildiz I., Varol U., Cokmert S., Alacacioglu A., Kucukzeybek Y., et al.

WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY , cilt.19, ss.385-390, 2015 (ESCI, Scopus)

15. Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology

Kaplan M. A., Isikdogan A., Koca D., Kucukoner M., Gumusay O., Yildiz R., et al.

BREAST CANCER , cilt.21, ss.677-683, 2014 (SCI-Expanded, Scopus)

16. Acute Cardiotoxic Effects of Adjuvant Trastuzumab Treatment and its Relation to Oxidative Stress

Dirican A., Levent F., Alacacioglu A., Kucukzeybek Y., Varol U., Kocabas U., et al.

ANGIOLOGY , cilt.65, ss.951-952, 2014 (SCI-Expanded, Scopus)

17. Large Cell Neuroendocrine Carcinoma of the Ovary and Its Skin Metastases A Case Report and Review of the Literature

ÇOKMERT S., DEMİR L., DOĞANAY L., DEMİR N., ÜNEK İ. T., GEZER E., et al.

West Indian Medical Journal , cilt.63, sa.6, ss.667-672, 2014 (SCI-Expanded, Scopus)

18. Sexual satisfaction, anxiety, depression and quality of life in testicular cancer survivors

Alacacioglu A., Ulger E., Varol U., Yavuzsen T., Akyol M., Yildiz Y., et al.

MEDICAL ONCOLOGY , cilt.31, sa.7, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

19. The impact of cell proliferation markers and p53 mutation status on prognosis of non-metastatic colon cancer

DEMİR L., Ekinci N., Erten C., Somali I., Can A., Dirican A., et al.

JOURNAL OF SURGICAL ONCOLOGY , cilt.109, sa.7, ss.665-675, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

20. Prognostic Evaluation of Breast Cancer Patients with Evident Bone Marrow Metastasis

DEMİR L., Akyol M., Bener S., Payzin K. B., Erten C., Somali I., et al.

BREAST JOURNAL , cilt.20, sa.3, ss.279-287, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

21. Impact of pre-angiogenic factors on the treatment effect of bevacizumab in patients with metastatic colorectal cancer

Dirican A., Kucukzeybek Y., Alacacioglu A., Varol U., Aksun S., Bayoglu I. V., et al.

MEDICAL ONCOLOGY , cilt.31, sa.4, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

22. Clitoris metastasis from a retroperitoneal leiomyosarcoma A case report

ÇOKMERT S., DEMİR L., AKYOL M., BAYOĞLU İ. V., CAN A., ÜNEK İ. T., et al.

World Journal Of Clinical Oncology , cilt.5, sa.1, ss.28-32, 2014 (ESCI)

23. Survival Outcomes of Liver Metastasectomy in Colorectal Cancer Cases: A Single-Center Analysis in Turkey

Cokmert S., Ellidokuz H., DEMİR L., Fuzun M., Astarcioglu I., Aslan D., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, sa.13, ss.5195-5200, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

24. Second-Line Capecitabine and Oxaliplatin Combination for Gemcitabine-Resistant Advanced Pancreatic Cancer

Bayoglu I. V., Varol U., Yildiz I., Muslu U., Alacacioglu A., Kucukzeybek Y., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, sa.17, ss.7119-7123, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

25. Treatment of Metastatic Colorectal Cancer With or Without Bevacizumab: Can the Neutrophil/Lymphocyte Ratio Predict the Efficiency of Bevacizumab?

Dirican A., Varol U., Kucukzeybek Y., Alacacioglu A., Erten C., Somali I., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, sa.12, ss.4781-4786, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

26. Depression, Anxiety and Sexual Satisfaction in Breast Cancer Patients and their Partners-Izmir Oncology Group Study

Alacacioglu A., Ulger E., Varol U., Yildiz I., Salman T., Bayoglu V., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, sa.24, ss.10631-10636, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

27. Hormone Receptor, HER2/NEU and EGFR Expression in Ovarian Carcinoma - is here a Prognostic Phenotype?

DEMİR L., Yigit S., Sadullahoglu C., Akyol M., Cokmert S., Kucukzeybek Y., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, sa.22, ss.9739-9745, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

28. Capecitabine-related increased mean corpuscular volume of red blood cell may be a predictive marker of treatment response and survival in patients with metastatic colorectal cancer

Cokmert S., Demir L., Can A., Akyol M., Bayoglu I. V., Dirican A., et al.

JOURNAL OF BUON , cilt.19, sa.1, ss.75-82, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

29. Predictive and prognostic factors in locally advanced breast cancer: effect of intratumoral FOXP3+ Tregs

DEMİR L., Yigit S., Ellidokuz H., Erten C., Somali I., Kucukzeybek Y., et al.

CLINICAL & EXPERIMENTAL METASTASIS , cilt.30, sa.8, ss.1047-1062, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

30. The relationship of insulin resistance and metabolic syndrome with known breast cancer prognostic factors in postmenopausal breast cancer patients

Can A., Alacacioglu A., Kucukzeybek Y., Erten C., Cokmert S., Demir L., et al.

JOURNAL OF BUON , cilt.18, sa.4, ss.845-850, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

31. The association of hematologic parameters on the prognosis of patients with metastatic renal cell carcinoma

Dirican A., Kucukzeybek Y., Somali I., Erten C., Demir L., Can A., et al.

JOURNAL OF BUON , cilt.18, ss.413-419, 2013 (SCI-Expanded, Scopus)

32. One-day DCF regimen in patients with metastatic gastric cancer

Dirican A., Kucukzeybek Y., Tarhan M. O., Somali I., Erten C., DEMİR L., et al.

TUMORI J , cilt.99, sa.2, ss.145-148, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

33. The clinicopathological evaluation of the breast cancer patients with brain metastases: predictors of survival

Tarhan M. O., DEMİR L., Somali I., Yigit S., Erten C., Alacacioglu A., et al.

CLINICAL & EXPERIMENTAL METASTASIS , cilt.30, sa.2, ss.201-213, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

34. Prognostic and Predictive Value of Hematologic Parameters in Patients with Metastatic Renal Cell Carcinoma: Second Line Sunitinib Treatment Following IFN-alpha

Dirican A., Kucukzeybek Y., Erten C., Somali I., DEMİR L., Can A., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.14, sa.3, ss.2101-2105, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

35. Does Immunohistochemistry Provide Additional Prognostic Data in Gastrointestinal Stromal Tumors?

DEMİR L., Ekinci N., Erten C., Kucukzeybek Y., Alacacioglu A., Somali I., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.14, sa.8, ss.4751-4758, 2013 (SCI-Expanded, Scopus)

36. Clinicopathologic and Demographic Evaluation of Triple-Negative Breast Cancer Patients among a Turkish Patient Population: a Single Center Experience

Somali I., Ustaoglu B. Y., Tarhan M. O., Yigit S. C., DEMİR L., Ellidokuz H., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.14, sa.10, ss.6013-6017, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

37. The effects of hematological parameters and tumor-infiltrating lymphocytes on prognosis in patients with gastric cancer

Dirican A., Ekinci N., Avci A., Akyol M., Alacacioglu A., Kucukzeybek Y., et al.

CANCER BIOMARKERS , cilt.13, sa.1, ss.11-20, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

38. Prognostic Significance of Circulating Tumor Cells and Serum CA15-3 Levels in Metastatic Breast Cancer, Single Center Experience, Preliminary Results

Tarhan M. O., Gonel A., Kucukzeybek Y., Erten C., Cuhadar S., Yigit S. C., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.14, sa.3, ss.1725-1729, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

39. Malignant epithelioid hemangioendothelioma progressing after chemotherapy and Interferon treatment: A case presentation and a brief review of the literature

DEMİR L., Can A., Oztop R., Dirican A., Bayoglu V., Akyol M., et al.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , cilt.9, sa.1, ss.125-127, 2013 (SCI-Expanded, Scopus)

40. Cisplatin Plus Gemcitabine for Treatment of Breast Cancer Patients with Brain Metastases; a Preferential Option for Triple Negative Patients?

Erten C., DEMİR L., Somali I., Alacacioglu A., Kucukzeybek Y., Akyol M., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.14, sa.6, ss.3711-3717, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

41. Malignant Fibrous Histiocytoma of the Spermatic Cord in a Patient With Polycystic Kidney Disease; Review of the Literature

DEMİR L., Can A., Dirican A., Bayoglu V., Rezanko T. A., Akyol M., et al.

CLINICAL GENITOURINARY CANCER , cilt.10, sa.4, ss.280-283, 2012 (SCI-Expanded, Scopus)

42. Cutaneous and subcutaneous metastases from bladder carcinoma

Dirican A., Kucukzeybek Y., Somali I., Erten C., DEMİR L., Can A., et al.

WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY , cilt.16, sa.5, ss.451-452, 2012 (SCI-Expanded, Scopus)

43. Intramammary lymph node metastasis in a patient with ovarian carcinoma and a brief review of the literature

DEMİR L., Erten C., Yigit S. C., Can A., Dirican A., Bayoglu V., et al.

WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY , cilt.16, sa.2, ss.108-110, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

44. Re-evaluation of 129 patients with systemic necrotizing vasculitides by using classification algorithm according to consensus methodology

Kamali S., Artim-Esen B., Erer B., Ozdener L., GÜL A., Ocal L., et al.

CLINICAL RHEUMATOLOGY , cilt.31, sa.2, ss.325-328, 2012 (SCI-Expanded, Scopus)

45. Second-Line Irinotecan after Cisplatin, Fluoropyrimidin and Docetaxel for Chemotherapy of Metastatic Gastric Cancer

Kucukzeybek Y., Dirican A., Erten C., Somali I., Can A., DEMİR L., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.13, sa.6, ss.2771-2774, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

46. Biological Subtypes and Survival Outcomes in Breast Cancer Patients with Brain Metastases (Study of the Anatolian Society of Medical Oncology)

Kaplan M. A., Isikdogan A., Koca D., Kucukoner M., Gumusay O., Yildiz R., et al.

ONCOLOGY , cilt.83, sa.3, ss.141-150, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

47. The clinicopathological significance of Bax and Bcl-2 protein expression with tumor infiltrating lymphocytes in ovarian carcinoma

Yigit S., DEMİR L., Tarhan M. O., Cabuk F. K., Ellidokuz H., Erten C., et al.

NEOPLASMA , cilt.59, sa.5, ss.475-485, 2012 (SCI-Expanded, Scopus)

48. Micro-metastases into the uterine leiomyoma from invasive ductal breast cancer under adjuvant tamoxifen therapy: case report

Dirican A., Kucukzeybek Y., Somali I., Erten C., DEMİR L., Can A., et al.

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , cilt.33, sa.6, ss.652-655, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

49. Metastases of renal cell carcinoma to the larynx and thyroid: Two case reports on metastasis developing years after nephrectomy.

DEMİR L., ERTEN Ç., SOMALI I., CAN A., DİRİCAN A., BAYOĞLU İ. V., et al.

Canadian Urological Association Journal , cilt.6, sa.5, ss.209-212, 2012 (SCI-Expanded, Scopus)

50. The toxicity and efficacy of Nordic-FLOX regimen as adjuvant treatment of stage III colon cancer

DEMİR L., Somali I., Tarhan M. O., Erten C., Ellidokuz H., Can A., et al.

JOURNAL OF BUON , cilt.16, sa.4, ss.682-688, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 18

1. BAŞ BOYUN MALİGN PARAGANGLİOMA, VAKA BİLDİRİMİ

AKÇAY M. Ç., ETİZ D., DEMİR L., PINARBAŞLI M. Ö., ÖZEN A., GÜRBÜZ M. K.

6. Multidisipliner Baş Boyun Kanserleri Kongresi, Türkiye, 6 - 08 Mart 2020, (Özet Bildiri)

2. Nüks metastatik baş boyun kanseri hastalarında 1. seri Platin-5FU-Cetuximab tedavi sonuçlarının ve yan etkilerinin değerlendirilmesi, tek merkez deneyimi

Bayır D., Demir N., Ersoy M., Yıldız B., Demir L., Şaylısoy S., et al.

6. MULTİDİSİPLİNER BAŞ BOYUN KANSERLERİ KONGRESİ, Antalya, Türkiye, 5 - 08 Mart 2020, ss.48, (Tam Metin Bildiri)

18. Eskişehir Osmangazi Üniversitesi Prof. Dr. Servet Bilir Onkoloji Merkezinde takipli hepatoselüler kanserli hastaların klinik özellikleri ve prognostik faktörleri

Aliyev A., Dal P., Junushova B., Musmul A., Yıldız B., Demir L., et al.

22. ULUSAL KANSER KONGRESİ, Antalya, Türkiye, 19 - 23 Nisan 2017, ss.583-584, (Tam Metin Bildiri)

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

423

H-İndeks (WoS)

Atıf (Scopus)

470

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Proje

Tez Danışmanlığı

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler